A global biopharmaceutical company is investing $1 billion in a new drug manufacturing plant in greater Raleigh, North Carolina, the latest in a run of high-profile pharmaceutical projects in one of the top life sciences markets in the country.
A global biopharmaceutical company is investing $1 billion in a new drug manufacturing plant in greater Raleigh, North Carolina, the latest in a run of high-profile pharmaceutical projects in one of the top life sciences markets in the country.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
4100 Friendship Rd, Apex, NC